Health after coronary stenting or balloon angioplasty: Results from the stent restenosis study

H. M. Krumholz, D. J. Cohen, C. Williams, D. S. Baim, Jeffrey A Brinker, H. S. Cabin, R. Heuser, J. Hirshfeld, M. B. Leon, J. Moses, M. P. Savage, M. Cleman

Research output: Contribution to journalArticle

Abstract

This study was designed to compare health-related quality of life (HRQOL) in patients undergoing coronary stenting or balloon angioplasty in the randomized Stent Restenosis Study. The study sample was drawn from patients at nine U.S. clinical sites of the Stent Restenosis Study, a randomized trial comparing Palmaz-Schatz coronary stent implantation with conventional balloon angioplasty. One hundred ninety-nine consecutive patients were sent surveys 6 to 18 months after enrollment and 160 (80%) were returned. The survey sent to the patients included the Medical Outcomes Study 36-Item Short-Form Health Survey, the Canadian Cardiovascular Society Classification, and the Duke Activity Status Index. Although patients who underwent stenting had less angiographic restenosis and a tendency for fewer ischemic events, there were few differences in HRQOL after a mean of 456 days after randomization. The group that underwent stenting reported significantly less bodily pain than the group that underwent angioplasty (p=0.02). Otherwise, there were no significant differences in generic or disease- specific measures. In a rating of their overall health, 47% of the group that underwent stenting and 45% of the group that underwent percutaneous transluminal coronary angioplasty reported very good or excellent health. In each group, 60% of the patients reported being symptom free from a cardiovascular perspective. This survey revealed no marked differences in long-term HRQOL between patients who underwent Palmaz-Schatz coronary stenting compared with those who underwent conventional angioplasty.

Original languageEnglish (US)
Pages (from-to)337-344
Number of pages8
JournalAmerican Heart Journal
Volume134
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Balloon Angioplasty
Stents
Health
Quality of Life
Angioplasty
Coronary Balloon Angioplasty
Random Allocation
Health Surveys
Outcome Assessment (Health Care)
Pain
Surveys and Questionnaires

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Health after coronary stenting or balloon angioplasty : Results from the stent restenosis study. / Krumholz, H. M.; Cohen, D. J.; Williams, C.; Baim, D. S.; Brinker, Jeffrey A; Cabin, H. S.; Heuser, R.; Hirshfeld, J.; Leon, M. B.; Moses, J.; Savage, M. P.; Cleman, M.

In: American Heart Journal, Vol. 134, No. 3, 1997, p. 337-344.

Research output: Contribution to journalArticle

Krumholz, HM, Cohen, DJ, Williams, C, Baim, DS, Brinker, JA, Cabin, HS, Heuser, R, Hirshfeld, J, Leon, MB, Moses, J, Savage, MP & Cleman, M 1997, 'Health after coronary stenting or balloon angioplasty: Results from the stent restenosis study', American Heart Journal, vol. 134, no. 3, pp. 337-344. https://doi.org/10.1016/S0002-8703(97)70065-6
Krumholz, H. M. ; Cohen, D. J. ; Williams, C. ; Baim, D. S. ; Brinker, Jeffrey A ; Cabin, H. S. ; Heuser, R. ; Hirshfeld, J. ; Leon, M. B. ; Moses, J. ; Savage, M. P. ; Cleman, M. / Health after coronary stenting or balloon angioplasty : Results from the stent restenosis study. In: American Heart Journal. 1997 ; Vol. 134, No. 3. pp. 337-344.
@article{3e7902a80ece45ffb0e8acc0e5fd5944,
title = "Health after coronary stenting or balloon angioplasty: Results from the stent restenosis study",
abstract = "This study was designed to compare health-related quality of life (HRQOL) in patients undergoing coronary stenting or balloon angioplasty in the randomized Stent Restenosis Study. The study sample was drawn from patients at nine U.S. clinical sites of the Stent Restenosis Study, a randomized trial comparing Palmaz-Schatz coronary stent implantation with conventional balloon angioplasty. One hundred ninety-nine consecutive patients were sent surveys 6 to 18 months after enrollment and 160 (80{\%}) were returned. The survey sent to the patients included the Medical Outcomes Study 36-Item Short-Form Health Survey, the Canadian Cardiovascular Society Classification, and the Duke Activity Status Index. Although patients who underwent stenting had less angiographic restenosis and a tendency for fewer ischemic events, there were few differences in HRQOL after a mean of 456 days after randomization. The group that underwent stenting reported significantly less bodily pain than the group that underwent angioplasty (p=0.02). Otherwise, there were no significant differences in generic or disease- specific measures. In a rating of their overall health, 47{\%} of the group that underwent stenting and 45{\%} of the group that underwent percutaneous transluminal coronary angioplasty reported very good or excellent health. In each group, 60{\%} of the patients reported being symptom free from a cardiovascular perspective. This survey revealed no marked differences in long-term HRQOL between patients who underwent Palmaz-Schatz coronary stenting compared with those who underwent conventional angioplasty.",
author = "Krumholz, {H. M.} and Cohen, {D. J.} and C. Williams and Baim, {D. S.} and Brinker, {Jeffrey A} and Cabin, {H. S.} and R. Heuser and J. Hirshfeld and Leon, {M. B.} and J. Moses and Savage, {M. P.} and M. Cleman",
year = "1997",
doi = "10.1016/S0002-8703(97)70065-6",
language = "English (US)",
volume = "134",
pages = "337--344",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Health after coronary stenting or balloon angioplasty

T2 - Results from the stent restenosis study

AU - Krumholz, H. M.

AU - Cohen, D. J.

AU - Williams, C.

AU - Baim, D. S.

AU - Brinker, Jeffrey A

AU - Cabin, H. S.

AU - Heuser, R.

AU - Hirshfeld, J.

AU - Leon, M. B.

AU - Moses, J.

AU - Savage, M. P.

AU - Cleman, M.

PY - 1997

Y1 - 1997

N2 - This study was designed to compare health-related quality of life (HRQOL) in patients undergoing coronary stenting or balloon angioplasty in the randomized Stent Restenosis Study. The study sample was drawn from patients at nine U.S. clinical sites of the Stent Restenosis Study, a randomized trial comparing Palmaz-Schatz coronary stent implantation with conventional balloon angioplasty. One hundred ninety-nine consecutive patients were sent surveys 6 to 18 months after enrollment and 160 (80%) were returned. The survey sent to the patients included the Medical Outcomes Study 36-Item Short-Form Health Survey, the Canadian Cardiovascular Society Classification, and the Duke Activity Status Index. Although patients who underwent stenting had less angiographic restenosis and a tendency for fewer ischemic events, there were few differences in HRQOL after a mean of 456 days after randomization. The group that underwent stenting reported significantly less bodily pain than the group that underwent angioplasty (p=0.02). Otherwise, there were no significant differences in generic or disease- specific measures. In a rating of their overall health, 47% of the group that underwent stenting and 45% of the group that underwent percutaneous transluminal coronary angioplasty reported very good or excellent health. In each group, 60% of the patients reported being symptom free from a cardiovascular perspective. This survey revealed no marked differences in long-term HRQOL between patients who underwent Palmaz-Schatz coronary stenting compared with those who underwent conventional angioplasty.

AB - This study was designed to compare health-related quality of life (HRQOL) in patients undergoing coronary stenting or balloon angioplasty in the randomized Stent Restenosis Study. The study sample was drawn from patients at nine U.S. clinical sites of the Stent Restenosis Study, a randomized trial comparing Palmaz-Schatz coronary stent implantation with conventional balloon angioplasty. One hundred ninety-nine consecutive patients were sent surveys 6 to 18 months after enrollment and 160 (80%) were returned. The survey sent to the patients included the Medical Outcomes Study 36-Item Short-Form Health Survey, the Canadian Cardiovascular Society Classification, and the Duke Activity Status Index. Although patients who underwent stenting had less angiographic restenosis and a tendency for fewer ischemic events, there were few differences in HRQOL after a mean of 456 days after randomization. The group that underwent stenting reported significantly less bodily pain than the group that underwent angioplasty (p=0.02). Otherwise, there were no significant differences in generic or disease- specific measures. In a rating of their overall health, 47% of the group that underwent stenting and 45% of the group that underwent percutaneous transluminal coronary angioplasty reported very good or excellent health. In each group, 60% of the patients reported being symptom free from a cardiovascular perspective. This survey revealed no marked differences in long-term HRQOL between patients who underwent Palmaz-Schatz coronary stenting compared with those who underwent conventional angioplasty.

UR - http://www.scopus.com/inward/record.url?scp=9844253327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9844253327&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(97)70065-6

DO - 10.1016/S0002-8703(97)70065-6

M3 - Article

C2 - 9327686

AN - SCOPUS:9844253327

VL - 134

SP - 337

EP - 344

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -